Literature DB >> 20549463

Pleural dissemination of esophageal gastrointestinal stromal tumors after an eight-year interval following the primary surgery.

Kazuhiro Imai1, Hajime Saito, Yoshihiro Minamiya, Taku Nakagawa, Manabu Ito, Yukiko Hosono, Takashi Ono, Jun-ichi Ogawa.   

Abstract

A 71-year-old man who had undergone surgical resection of esophageal gastrointestinal stromal tumors (GISTs) through a right posterolateral thoracotomy 8 years earlier was referred for treatment of an anterior mediastinal mass discovered on a follow-up chest radiograph in October 2007. Computed tomography findings revealed a tumor, 82 x 49 mm, with calcification, in the anterior mediastinum. When we radically resected the tumor via a median sternectomy, we found that it was actually located in the pleural cavity, and there was a small nodule near the main tumor on other pleura. Microscopically, the tumor was comprised of uniform spindle cells with fibrillary eosinophilic cytoplasm. In addition, immunostaining showed that the tumor was positive for CD117 (c-kit). The diagnosis was pleural dissemination of esophageal GISTs 8 years after primary surgery, making this the first report of pleural dissemination of esophageal GISTs after such a prolonged postsurgical interval.

Entities:  

Mesh:

Year:  2010        PMID: 20549463     DOI: 10.1007/s11748-009-0554-6

Source DB:  PubMed          Journal:  Gen Thorac Cardiovasc Surg        ISSN: 1863-6705


  9 in total

1.  Gastrointestinal stromal tumor of the posterior mediastinum.

Authors:  Jeffrey R Lee; Mark P Anstadt; Shamsuddin Khwaja; Linda K Green
Journal:  Eur J Cardiothorac Surg       Date:  2002-12       Impact factor: 4.191

2.  Gastrointestinal autonomic nerve tumor: immunohistochemical and molecular identity with gastrointestinal stromal tumor.

Authors:  J R Lee; V Joshi; J W Griffin ; J Lasota; M Miettinen
Journal:  Am J Surg Pathol       Date:  2001-08       Impact factor: 6.394

3.  The epidemiology of malignant gastrointestinal stromal tumors: an analysis of 1,458 cases from 1992 to 2000.

Authors:  Thomas Tran; Jessica A Davila; Hashem B El-Serag
Journal:  Am J Gastroenterol       Date:  2005-01       Impact factor: 10.864

Review 4.  Gastrointestinal stromal tumors--definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis.

Authors:  M Miettinen; J Lasota
Journal:  Virchows Arch       Date:  2001-01       Impact factor: 4.064

5.  Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: a phase I study.

Authors:  A T van Oosterom; I Judson; J Verweij; S Stroobants; E Donato di Paola; S Dimitrijevic; M Martens; A Webb; R Sciot; M Van Glabbeke; S Silberman; O S Nielsen
Journal:  Lancet       Date:  2001-10-27       Impact factor: 79.321

6.  Gastric stromal tumors. Reappraisal of histogenesis.

Authors:  M T Mazur; H B Clark
Journal:  Am J Surg Pathol       Date:  1983-09       Impact factor: 6.394

7.  Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors.

Authors:  George D Demetri; Margaret von Mehren; Charles D Blanke; Annick D Van den Abbeele; Burton Eisenberg; Peter J Roberts; Michael C Heinrich; David A Tuveson; Samuel Singer; Milos Janicek; Jonathan A Fletcher; Stuart G Silverman; Sandra L Silberman; Renaud Capdeville; Beate Kiese; Bin Peng; Sasa Dimitrijevic; Brian J Druker; Christopher Corless; Christopher D M Fletcher; Heikki Joensuu
Journal:  N Engl J Med       Date:  2002-08-15       Impact factor: 91.245

8.  NCCN Task Force report: optimal management of patients with gastrointestinal stromal tumor (GIST)--expansion and update of NCCN clinical practice guidelines.

Authors:  George D Demetri; Robert Benjamin; Charles D Blanke; Haesun Choi; Chris Corless; Ronald P DeMatteo; Burton L Eisenberg; Christopher D M Fletcher; Robert G Maki; Brian P Rubin; Annick D Van den Abbeele; Margaret von Mehren
Journal:  J Natl Compr Canc Netw       Date:  2004-05       Impact factor: 11.908

9.  Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial.

Authors:  Ronald P Dematteo; Karla V Ballman; Cristina R Antonescu; Robert G Maki; Peter W T Pisters; George D Demetri; Martin E Blackstein; Charles D Blanke; Margaret von Mehren; Murray F Brennan; Shreyaskumar Patel; Martin D McCarter; Jonathan A Polikoff; Benjamin R Tan; Kouros Owzar
Journal:  Lancet       Date:  2009-03-18       Impact factor: 79.321

  9 in total
  2 in total

1.  Esophageal gastrointestinal stromal tumor: report of 7 patients.

Authors:  A B Shinagare; K A Zukotynski; K M Krajewski; J P Jagannathan; J Butrynski; J L Hornick; N H Ramaiya
Journal:  Cancer Imaging       Date:  2012-04-27       Impact factor: 3.909

2.  Clinicopathologic Features and Clinical Outcomes of Esophageal Gastrointestinal Stromal Tumor: Evaluation of a Pooled Case Series.

Authors:  Fan Feng; Yangzi Tian; Zhen Liu; Guanghui Xu; Shushang Liu; Man Guo; Xiao Lian; Daiming Fan; Hongwei Zhang
Journal:  Medicine (Baltimore)       Date:  2016-01       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.